- Investing Ideas
- Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
Strides Pharma Science
Market Cap: ₹95.9b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹1,040.70
7D
-1.8%
1Y
13.3%
Viyash Scientific
Market Cap: ₹112.1b
Operates in the veterinary healthcare business in Europe, Asia, and internationally.
New
512529
₹256.90
7D
-8.3%
1Y
37.3%